Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
RegulatoryapprovedSarclisa EscenaPositive
AI Analysis
Summary
Sanofi received FDA approval for Sarclisa Escena, a subcutaneous formulation administered via on-body injector, marking the first anticancer treatment with this delivery mechanism in the United States.
Outcome Details
US FDA approval as first anticancer treatment administered via on-body injector, subcutaneous formulation
Importance:8/10
Sentiment:
0.80
FDA approvaloncologysubcutaneousdrug delivery innovationfirst-in-class formulation
Related Companies
Read the original article
Published by GlobeNewswire Pharma on July 10, 2026 12:35 PM